The sudden removal of the fast-acting Fiasp insulin from Australia’s PBS subsidy system has been a source of major heartache amongst the diabetes community. But we had a glimmer of hope this morning. The Federal Health Minister (Mark Butler MP) has announced that instead of Fiasp being summarily deleted from PBS, it’s going into “Supply …
How much do we pay for insulin in Australia? Usually in Australia insulin has been available in three formats: 10 mL vials 3 mL pen cartridges (“Penfill” is the name for the Novo cartridges, but the Sanofi and Lilly cartridges have the same capacity) 3 mL disposable pens Using different formats I started off with …
Economics of insulin from a PBS-user perspective Read More »
I have a suspicion about some of the background to the current Fiasp drama, where Novo seems to have been pressured to remove Fiasp from PBS listing. Stories are rarely simple. I don’t know this is the complete story, but I’ll try to stick to recounting known facts! This is a potted history of one …
I’ve had a few people ask whether PBS was actually going to de-list Fiasp. None of us wanted it to be real. They have now quietly made the announcement, buried within the monthly list of changes.
The recent news about Fiasp insulin being removed from the Australian Government’s Pharmaceutical Benefits Scheme (PBS) from April has seen many people in the community ask “Why is Diabetes Australia not saying anything?” The grapevine says that media releases will happen on March 1st (tomorrow). There will at least be a line item hidden in …
I’ve been spending this week in Berlin attending the ATTD 2023 conference. as part of the #dedoc˚ voices. It’s only half done so far. There’s a flood of presentations to attend, study results to absorb, and literally thousands of other people to talk to. It’s very hectic. But in the background I’ve become aware of …